Display options
Share it on

BMJ Open. 2021 Dec 06;11(12):e048575. doi: 10.1136/bmjopen-2020-048575.

Prevalence and risk factors for hyperhomocysteinemia: a population-based cross-sectional study from Hunan, China.

BMJ open

Yide Yang, Yuan Zeng, Shuqian Yuan, Ming Xie, Yanhui Dong, Jian Li, Quanyuan He, Xiangli Ye, Yuan Lv, Carl-Friedrich Hocher, Bernhard K Kraemer, Xiuqin Hong, Berthold Hocher

Affiliations

  1. Key Laboratory of Molecular Epidemiology of Hunan Province, School of Medicine, Hunan Normal University, Changsha, Hunan, China.
  2. Institute of Child and Adolescent Health, School of Public Health, Peking University Health Science Center, Beijing, Beijing, China.
  3. Key Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, School of Medicine, Hunan Normal University, Changsha, Hunan, China.
  4. Fifth Department of Medicine (Nephrology/Endocrinology/Rheumatology), University Medical Centre Mannheim, University of Heidelberg, Mannheim, Germany.
  5. Key Laboratory of Molecular Epidemiology of Hunan Province, School of Medicine, Hunan Normal University, Changsha, Hunan, China [email protected] [email protected].
  6. Key Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, School of Medicine, Hunan Normal University, Changsha, Hunan, China [email protected] [email protected].
  7. Reproductive and Genetic Hospital of CITIC-Xiangya, Changsha, Hunan Province, China.
  8. Institute of Medical Diagnostics, IMD Berlin, Berlin, Germany.

PMID: 34872994 PMCID: PMC8650492 DOI: 10.1136/bmjopen-2020-048575

Abstract

OBJECTIVES: Hyperhomocysteinemia is an independent risk factor for cardiovascular diseases. We aimed to investigate the prevalence and risk factors for hyperhomocysteinemia, especially modifiable lifestyle factors, such as smoking behaviour and dietary factors.

DESIGN: Population-based cross-sectional study.

SETTING: Hunan Province, China PARTICIPANTS: A total of 4012 participants completed the study, between July 2013 and March 2014. The median age is 55 (interquartile range: 45-63) years, with 1644 males (41%) and 2368 females (59%).

MAIN OUTCOME MEASURES: Homocysteine level were measured by the microplate enzyme immunoassay method. Hyperthomocysteinemia was defined as ≥15 µmol/L. Questionnaire was used to investigate potential risk factors of hyperhomocysteinemia. Crude odd ratio (OR) or adjusted OR with 95% CI were determined by using univariable or multivariable logistic regression models.

RESULTS: The prevalence of hyperhomocysteinemia is 35.4% (45.4% vs 28.5% for men, women, respectively). One-year increase in age is significantly associated with 2% higher risk of hyperhomocysteinemia (OR=1.02, 95% CI: 1.01 to 1.03). One unit increase of BMI is associated with 5% higher risk of hyperhomocysteinemia (OR=1.05, 95% CI: 1.03 to 1.07). Compared with the non-smoker, smoking participants have a 24% higher risk of hyperhomocysteinemia (OR=1.24, 95% CI: 1.006 to 1.53), while the risk for those quitting smoking are not significantly different (OR=1.14, 95% CI: 0.85 to 1.54). compared with those consuming fruit and vegetable at least once every day, those consuming less than once every day had a significantly higher risk of hyperhomocysteinemia (OR=1.29, 95% CI:1.11 to 1.50). In addition, we found there were significant sex interaction with education level or alcohol drinking on the risk of hyperhomocysteinemia (p

CONCLUSIONS: Higher BMI and older age are potential risk factors for hyperhomocysteinemia. Current smoking but not quitting smoking is associated with higher risk of hyperhomocysteinemia. Fruit and vegetable consumption may have protective effect against hyperhomocysteinemia. Alcohol consumption or education level might interact to influence the risk of hyperhomocysteinemia.

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Keywords: adult cardiology; epidemiology; risk management

Conflict of interest statement

Competing interests: None declared.

References

  1. BMJ Open. 2019 Nov 25;9(11):e031414 - PubMed
  2. Am J Clin Nutr. 2001 Feb;73(2):232-9 - PubMed
  3. BMJ. 2014 Oct 01;349:g5878 - PubMed
  4. Am J Clin Nutr. 1996 Feb;63(2):220-4 - PubMed
  5. Public Health Nutr. 2010 Dec;13(12):1974-81 - PubMed
  6. J Nutr. 2007 Feb;137(2):407-13 - PubMed
  7. BMJ. 2002 Nov 23;325(7374):1202 - PubMed
  8. BMC Public Health. 2019 Apr 30;19(1):458 - PubMed
  9. Br J Nutr. 2013 Apr 14;109(7):1284-93 - PubMed
  10. Ann Nutr Metab. 2015;67(1):1-12 - PubMed
  11. Curr Med Chem. 2019;26(16):2948-2961 - PubMed
  12. Br J Nutr. 2015 Feb 28;113(4):691-8 - PubMed
  13. J Nutr Health Aging. 2014;18(8):730-6 - PubMed
  14. Ethn Dis. 2004 Autumn;14(4):476-82 - PubMed
  15. Biomarkers. 2020 Mar;25(2):126-130 - PubMed
  16. J Neurol Neurosurg Psychiatry. 2006 Oct;77(10):1150-6 - PubMed
  17. J Korean Med Sci. 2010 Apr;25(4):509-16 - PubMed
  18. BMJ Open. 2017 Jun 2;7(5):e015476 - PubMed
  19. Nutr Res Pract. 2015 Oct;9(5):503-10 - PubMed
  20. JAMA. 1995 Nov 15;274(19):1526-33 - PubMed
  21. Nutrients. 2020 May 18;12(5): - PubMed
  22. Lancet. 2000 Apr 29;355(9214):1522 - PubMed
  23. Cleve Clin J Med. 2010 Dec;77(12):911-8 - PubMed
  24. Nutr Metab Cardiovasc Dis. 2019 Jan;29(1):9-14 - PubMed
  25. JAMA. 1997 Jun 11;277(22):1775-81 - PubMed
  26. Sci Total Environ. 2020 Sep 10;734:139411 - PubMed
  27. Atherosclerosis. 2008 Jun;198(2):412-8 - PubMed
  28. Biomed Res Int. 2020 Jan 11;2020:9210261 - PubMed
  29. Ann Intern Med. 2003 Jun 3;138(11):891-7 - PubMed
  30. J Nutr. 2006 Jun;136(6 Suppl):1731S-1740S - PubMed
  31. Nutrients. 2014 Dec 29;7(1):74-90 - PubMed
  32. Eur J Hum Genet. 2008 Oct;16(10):1164-72 - PubMed
  33. J Am Coll Nutr. 1996 Aug;15(4):364-76 - PubMed
  34. Am J Pathol. 1969 Jul;56(1):111-28 - PubMed
  35. Eur J Clin Nutr. 2009 Jan;63(1):18-30 - PubMed
  36. Front Cardiovasc Med. 2020 Nov 23;7:590809 - PubMed
  37. J Am Diet Assoc. 2000 Aug;100(8):886-7 - PubMed
  38. J Chin Med Assoc. 2017 Mar;80(3):147-153 - PubMed
  39. Clin Nutr. 2018 Jun;37(3):1061-1065 - PubMed
  40. Clin Exp Hypertens. 2016;38(8):691-695 - PubMed
  41. Eur J Clin Nutr. 2019 May;73(5):724-732 - PubMed
  42. Am J Clin Nutr. 2016 Jan;103(1):39-49 - PubMed
  43. PLoS One. 2014 Nov 03;9(11):e111619 - PubMed
  44. J Neurol Sci. 2010 Nov 15;298(1-2):153-7 - PubMed
  45. Eur J Nutr. 2008 Jun;47(4):201-9 - PubMed
  46. Am J Physiol Renal Physiol. 2007 Aug;293(2):F594-600 - PubMed
  47. JAMA Intern Med. 2019 Jun 1;179(6):777-785 - PubMed
  48. Amino Acids. 2014 Aug;46(8):1795-804 - PubMed
  49. Hum Psychopharmacol. 2020 Mar;35(2):e2724 - PubMed
  50. BMC Cardiovasc Disord. 2020 Feb 11;20(1):73 - PubMed
  51. Nutrients. 2013 Aug 15;5(8):3235-56 - PubMed
  52. Eur J Clin Nutr. 2002 Jul;56(7):608-14 - PubMed
  53. Am J Clin Nutr. 2001 Mar;73(3):613-21 - PubMed
  54. Eur J Clin Nutr. 2007 Jan;61(1):111-8 - PubMed
  55. Clin Physiol Funct Imaging. 2017 Nov;37(6):669-674 - PubMed
  56. J Am Coll Cardiol. 2011 Aug 30;58(10):1025-33 - PubMed
  57. Clin Exp Hypertens. 2018;40(5):495-500 - PubMed
  58. Int J Mol Sci. 2016 Oct 20;17(10): - PubMed
  59. Am J Clin Nutr. 2003 Apr;77(4):826-33 - PubMed

Publication Types